Faculty Information - Yamaguchi Rei

（Last updated : 2024-03-26 17:52:02）

Yamaguchi Rei
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Rheumatology

Position

■ Published papers

1.	Original article	Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort 2024/02/26
2.	Original article	Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort. 2023/06/28
3.	Case report	A case of systemic lupus erythematosus having concurrent Evans syndrome and acquired thrombotic thrombocytopenic purpura. 2023/02/08
4.	Original article	Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort. 2022/10/15
5.	Original article	Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort. 2022/08/20
6.	Original article	Trends in Risks of Malignancies in Japanese Patients with Rheumatoid Arthritis: Analyses from a 14-year Observation of the IORRA Cohort. 2022/08/03
7.	Original article	Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort. 2022/07/01
8.	Original article	Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids. 2022/04/18
9.	Original article	Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data. 2022
10.	Original article	Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings. 2021/07/04
11.	Original article	Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings. 2021/07
12.	Original article	Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan. 2016/07
Display 5 items
Display all(12)

■ Academic conference presentation

1.	Real world evidence of treatment effectiveness and unfavorable clinical events for elderly-onset early rheumatoid arthritis in Japan: Results from the IORRA study 2022/11/12
2.	Factors associated with treatment response in patients with elderly-onset rheumatoid arhthritis: 3-year observation using IORRA cohort 2020/08/04
3.	Factors associated with treatment response in patients with elderly-onset rheumatoid arhthritis: 3-year observation using IORRA cohort 2020/06/03